Sen. Cory Booker (D-NJ) recently announced he will no longer accept donations from pharma companies due to public criticism. Booker also argued that drug pricing is a bipartisan issue Congress could pursue to improve the U.S. health care system, and is a more useful pursuit than attempting to repeal and replace Obamacare. “[W]e have a crisis in this country with the expense of prescription drugs. What we should be doing is coming together as national leaders,” Booker told National Public...